PMA device
ExAblate Neuro Thalamotomy
Insightec · Mr-Guided Focused Ultrasound System (POH, Class III) · First FDA decision Sep 29, 2016, newest Oct 13, 2017Essential tremorParkinson's disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
20
Naming "ExAblate Neuro Thalamotomy"
MAUDE reports
0
Brand "ExAblate Neuro Thalamotomy", since 2015
PubMed studies
0
Mentioning "ExAblate Neuro Thalamotomy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ExAblate Neuro Thalamotomy
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- ExAblate Neuro ThalamotomyPMA supplement
P150038-S004 · Decided Oct 13, 2017 · 58 days after receipt · Normal 180 Day Track No User Fee
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
- EXABLATE NEURO THALAMOTOMYPMA supplement
P150038-S001 · Decided Sep 29, 2016 · 57 days after receipt · Normal 180 Day Track No User Fee
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for TremorProposed local determinationProposedDL37421National Government Services, Inc.Updated Sep 18, 2025
- Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's DiseaseLocal determinationIn effectL37729Noridian Healthcare Solutions, LLCUpdated Sep 2, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "ExAblate Neuro Thalamotomy", any status and sponsor, newest update first.
- A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset EpilepsyActive, not recruiting
University of North Carolina, Chapel HillAcademic, hospital or other
NCT03417297 · 10 participants (planned) · Start Apr 24, 2018 · Primary completion May 2028
Device: High Intensity Focused Ultrasound · For: Partial Seizures With Secondary Generalization; Focal Epilepsy With Secondary Generalization
Sites: Chapel Hill, North Carolina
- The Impact of Focused Ultrasound Thalamotomy of the Anterior Nucleus for Focal-Onset Epilepsy on AnxietyActive, not recruiting
Ohio State UniversityAcademic, hospital or other
NCT05032105 · 2 participants · Start Jun 4, 2024 · Primary completion Dec 31, 2027
Device: Magnetic Resonance Imaging-guided Focused Ultrasound Ablation (MRgFUSA) · For: Anxiety; Medication-refractory Focal-onset Epilepsy
Sites: Columbus, Ohio
- MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal NeuralgiaActive, not recruiting
University of Maryland, BaltimoreAcademic, hospital or other
NCT04579692 · 10 participants · Start Aug 16, 2021 · Primary completion May 28, 2026
Device: ExAblate Transcranial treatment · For: Trigeminal Neuralgia
Sites: Baltimore, Maryland
17 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ExAblate Neuro Thalamotomy", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code POH
262 reports: 2 malfunction, 254 injury, 5 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ExAblate Neuro Thalamotomy"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code POH.
- Exablate Model 4000 SystemInsightec · PMA 2026
- Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)Insightec · PMA 2022
- Exablate NeuroInsightec · PMA 2024
- Exablate 4000 (Neuro) Type 1.0 & 1.1Insightec · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.